Similar effects were also observed for lymphoma cell lines representative of aberrant MYC activity (CA-46) or constitutive Jak/STAT and NF-kB pathway activation (OCI-Ly3, L-428) (Fig. 3b). The gene discussed is SOAT1; the disease is lymphoma.